Table 1.
Correlations between L1cam expression and clinicopathological characteristics in gastric cancer patients
|
|
L1cam expression |
|
|
---|---|---|---|---|
Characteristics | Total no. |
Low No. cases (%) |
High No. cases (%) |
P value |
Age |
|
|
|
0.169 |
< 60 |
97 |
57(67) |
40(56) |
|
≥ 60 |
59 |
28(33) |
31(44) |
|
Gender |
|
|
|
0.342 |
Male |
106 |
55(64) |
51(72) |
|
Female |
50 |
30(36) |
20(28) |
|
Tumor size |
|
|
|
0.001a |
<5 cm |
101 |
65(76) |
36(51) |
|
≥5 cm |
55 |
20(24) |
35(49) |
|
Differentiation status |
|
|
|
0.290 |
Well |
9 |
7(8) |
2(3) |
|
Moderate |
87 |
48(56) |
39(55) |
|
Poor and others |
60 |
30(36) |
30(42) |
|
Lymph node invasion |
|
|
|
0.007a |
Absent |
69 |
46(54) |
23(32) |
|
Present |
87 |
39(46) |
48(68) |
|
Venous invasion |
|
|
|
0.077 |
Absent |
91 |
55(65) |
36(51) |
|
Present |
65 |
30(35) |
35(49) |
|
Peritoneal dissemination |
|
|
|
0.019a |
Absent |
123 |
73(86) |
50(70) |
|
Present |
33 |
12(14) |
21(30) |
|
Liver metastasis |
|
|
|
0.013a |
Absent |
114 |
69(81) |
45(63) |
|
Present |
42 |
16(19) |
26(37) |
|
TNMb stage |
|
|
|
0.002a |
I-II |
48 |
35(41) |
13(18) |
|
III-IV |
108 |
50(59) |
58(82) |
|
Therapeutic strategy |
|
|
|
0.489 |
Surgery only |
86 |
49(58) |
37(52) |
|
Surgery + Chemotherapy |
70 |
36(42) |
34(48) |
|
Survival status |
|
|
|
< 0.001a |
Alive |
72 |
52(61) |
20(28) |
|
Dead | 84 | 33(39) | 51(72) |
aP < 0.05, Chi-square test.
bTNM, T, tumor; N, lymph node; M, distant metastasis.